Guanze Medical Information Industry (Holding) Co (HKSE:02427) Altman Z-Score: 38.82 (As of Jul. 26, 2026) — 299% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02427 Guanze Medical Information Industry (Holding) Co Ltd HKSE:02427
52 GF Score
Price HK$2.80
GF Value HK$0.28
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Guanze Medical Information Industry (Holding) Co Altman Z-Score?

Guanze Medical Information Industry (Holding) Co HKSE:02427 +12.00% 52 Altman Z-Score is 38.82 as of Jul. 26, 2026, which is 299% above its 10-year median of 9.73. GuruFocus rates HKSE:02427 with a GF Score™ of 52/100 and a GF Value™ of HK$0.28 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 202 Medical Diagnostics & Research companies, Guanze Medical Information Industry (Holding) Co ranks better than 99.5% on this metric.

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 38.82 is strong.

Guanze Medical Information Industry (Holding) Co has a Altman Z-Score of 38.82, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Guanze Medical Information Industry (Holding) Co's Altman Z-Score or its related term are showing as below:

HKSE:02427' s Altman Z-Score Range Over the Past 10 Years
Min: 6.26   Med: 9.73   Max: 38.82
Current: 38.82

During the past 7 years, Guanze Medical Information Industry (Holding) Co's highest Altman Z-Score was 38.82. The lowest was 6.26. And the median was 9.73.


Guanze Medical Information Industry (Holding) Co  (HKSE:02427) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Guanze Medical Information Industry (Holding) Co Altman Z-Score Related Terms


Guanze Medical Information Industry (Holding) Co Altman Z-Score Historical Data

* Premium members only.

The historical data trend for Guanze Medical Information Industry (Holding) Co's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guanze Medical Information Industry (Holding) Co Altman Z-Score Chart

Guanze Medical Information Industry (Holding) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z-Score
Get a 7-Day Free Trial 0.00 13.97 11.13 6.26 8.33

Guanze Medical Information Industry (Holding) Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.13 0.00 6.26 0.00 8.33

HKSE:02427 vs TMO, DHR, IDXX: Altman Z-Score Comparison

For the Diagnostics & Research subindustry, Guanze Medical Information Industry (Holding) Co's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guanze Medical Information Industry (Holding) Co Altman Z-Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guanze Medical Information Industry (Holding) Co's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Guanze Medical Information Industry (Holding) Co's Altman Z-Score falls into.


HKSE:02427
52GF Score
Guanze Medical Information Industry (Holding) Co Ltd HKSE:02427
Altman Z-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guanze Medical Information Industry (Holding) Co Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Guanze Medical Information Industry (Holding) Co's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.6473+1.4*0.344+3.3*-0.114+0.6*62.6826+1.0*0.3267
=38.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2025:
Total Assets was HK$299.04 Mil.
Total Current Assets was HK$235.58 Mil.
Total Current Liabilities was HK$42.03 Mil.
Retained Earnings was HK$102.88 Mil.
Pre-Tax Income was HK$-34.66 Mil.
Interest Expense was HK$-0.57 Mil.
Revenue was HK$97.71 Mil.
Market Cap (Today) was HK$2,660.00 Mil.
Total Liabilities was HK$42.44 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(235.583 - 42.029)/299.037
=0.6473

X2=Retained Earnings/Total Assets
=102.882/299.037
=0.344

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-34.664 - -0.574)/299.037
=-0.114

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=2660.000/42.436
=62.6826

X5=Revenue/Total Assets
=97.71/299.037
=0.3267

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Guanze Medical Information Industry (Holding) Co has a Altman Z-Score of 38.82 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.

Frequently Asked Questions Learn more about Altman Z-Score →
What does a Altman Z-Score of 38.82 mean?
Guanze Medical Information Industry (Holding) Co (HKSE:02427) has a Altman Z-Score of 38.82 as of Jul. 26, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Guanze Medical Information Industry (Holding) Co and its competitors. This is 299% above median its historical median of 9.73. Over the past decade, Guanze Medical Information Industry (Holding) Co's Altman Z-Score has ranged from 6.26 to 38.82. According to the industry distribution chart, Guanze Medical Information Industry (Holding) Co ranks #1 out of 202 companies in the Medical Diagnostics & Research industry, placing it in the top 0.5%.
Is Guanze Medical Information Industry (Holding) Co's Altman Z-Score too high?
Guanze Medical Information Industry (Holding) Co's current Altman Z-Score of 38.82 is 299% above median its 10-year median of 9.73. Over the past 10 years, this metric has ranged from a low of 6.26 to a high of 38.82. The Medical Diagnostics & Research industry median Altman Z-Score is 2.43. Guanze Medical Information Industry (Holding) Co's value of 38.82 is 1500.8% above this industry median. Based on the distribution chart, Guanze Medical Information Industry (Holding) Co ranks #1 out of 202 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Guanze Medical Information Industry (Holding) Co has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guanze Medical Information Industry (Holding) Co's Altman Z-Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Guanze Medical Information Industry (Holding) Co ranks #1 out of 202 companies for Altman Z-Score. This places Guanze Medical Information Industry (Holding) Co in the top 1% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 2.43. Guanze Medical Information Industry (Holding) Co's value of 38.82 is 1500.8% above this benchmark. Historically, Guanze Medical Information Industry (Holding) Co's own Altman Z-Score has ranged from 6.26 to 38.82 over the past decade. While the company's 10-year median is 9.73 vs. the industry median of 2.43, Guanze Medical Information Industry (Holding) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Medical Diagnostics & Research company?
The median Altman Z-Score among Medical Diagnostics & Research companies is 2.43, based on 202 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guanze Medical Information Industry (Holding) Co's current Altman Z-Score of 38.82 is 1500.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Guanze Medical Information Industry (Holding) Co and its competitors. For the Medical Diagnostics & Research industry, the median Altman Z-Score is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guanze Medical Information Industry (Holding) Co's current Altman Z-Score is 38.82, which is 299% above median its own 10-year median of 9.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guanze Medical Information Industry (Holding) Co stock overvalued right now?
Based on GuruFocus' analysis, Guanze Medical Information Industry (Holding) Co (HKSE:02427) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.28, compared to a current price of HK$2.80 — trading 900% above its estimated fair value. The current Altman Z-Score is 38.82, which is 299% above median its 10-year median of 9.73 and 1500.8% above the Medical Diagnostics & Research industry median of 2.43. Guanze Medical Information Industry (Holding) Co's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Guanze Medical Information Industry (Holding) Co (HKSE:02427), the current Altman Z-Score is 38.82 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guanze Medical Information Industry (Holding) Co (HKSE:02427) Overvalued in 2026?

Based on GuruFocus' analysis, Guanze Medical Information Industry (Holding) Co stock appears to be overvalued. The current stock price of HK$2.80 is trading 900% above its estimated GF Value™ of HK$0.28. GuruFocus considers Guanze Medical Information Industry (Holding) Co to be Significantly Overvalued.

Key valuation signals for HKSE:02427:

  • Altman Z-Score: 38.82 (299% above median its 10-year median of 9.73)
  • GF Value™: HK$0.28 vs. price of HK$2.80 (900% above fair value)
  • GF Score™: 52/100 with 4 warning signs
  • Industry Position: 1500.8% above the Medical Diagnostics & Research median (#1 of 202)

No single metric tells the full story. See the HKSE:02427 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guanze Medical Information Industry (Holding) Co Business Description

Address No. 2966 Chunhui Road, Room 501-A, Block 10 Strategic Emerging Industry Base, Jinan High-tech Zone, Shandong Province, Jinan, CHN
Guanze Medical Information Industry (Holding) Co Ltd is a medical imaging solutions provider, principally engaged in providing medical imaging film products and medical imaging cloud services in Shandong Province. The company generates the majority of its revenue from the PRC.
52GF Score

Get the complete analysis for HKSE:02427

Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.80
Price
HK$0.28
GF Value